Peripheral neuropathy Board decisions

The Board dismissed all service connection claims due to the Veteran's death, as there is no substituted appellant for this appeal.

The Board remands the claims for service connection for colon cancer, abdominal scar status post bowel resection, and chemotherapy-induced peripheral neuropathy due to inadequate VA examination opinions.

The Board granted a rating of 20 percent for the Veteran's left lower extremity diabetic peripheral neuropathy associated with herbicide agent exposure, resolving all doubt in favor of the Veteran.

The Board denied readjudication of increased rating claims for diabetes mellitus, bilateral knee, bilateral lower extremity peripheral neuropathy, and cervical spine, as well as an earlier effective date for DEA and entitlement to TDIU due to the lack of new and relevant evidence.

The Board denied evaluations in excess of 10 percent for neuropathy and a compensable rating for hypertension, as well as an evaluation in excess of 20 percent for diabetes mellitus type II.

The Board denied service connection for a vision disability, an upper body rash, and a right hand disability as the evidence did not support a finding that any of these conditions were related to the Veteran's active duty service.

The Board granted ratings of 30 to 40 percent for various diabetic neuropathies and restored a 10 percent rating for hypertension, while denying an increased rating for diabetes mellitus type II.

The Board dismissed the veteran's appeals for service connection for various conditions, including foot and calf pain, hammertoes, hallux valgus, and cervical spine degenerative arthritis.

The Veteran is granted a total disability rating based on individual unemployability (TDIU) and an effective date of August 13, 2019, for the grant of Special Monthly Compensation (SMC) based on the need for aid and attendance.

The Board granted an effective date of December 8, 2017, for the grant of service connection for rhinitis but denied initial compensable ratings and higher ratings for other conditions.

The Board granted service connection for bilateral upper and lower extremity peripheral neuropathy, secondary to diabetes mellitus type II.

The Board granted earlier effective dates of January 10, 2017, for the award of service connection for voiding dysfunction and peripheral neuropathy in all extremities.

The Board granted service connection for a right knee disability and denied service connection for right shoulder scars. The claims for peripheral neuropathy of the left thumb, a right ankle disorder, and a left ankle disorder were remanded.

The Board dismissed the appeal for earlier effective dates of service connection for various peripheral neuropathies due to a prohibited concurrent election.

The Board granted service connection for GERD, left and right upper extremity peripheral neuropathy, left and right lower extremity peripheral neuropathy, emphysema, and COPD.

The Board denied service connection for the veteran's lumbar spine, cervical spine, cervical radiculopathy or peripheral neuropathy of the bilateral upper extremities, and lumbar radiculopathy or sciatica of the bilateral lower extremities as there was no evidence to support a relationship between these conditions and his active military service.

The Board denied service connection for peripheral neuropathy of the right and left lower extremities as they did not originate in service or within a year after service, and were not related to any established in-service exposures.

The Board denied service connection for multiple disabilities, including a right hip disability, left ankle disability, right trigger finger disability, acquired psychiatric disorder, obstructive sleep apnea (OSA), and hypertension.

The Board remands the claims for service connection for right and left lower extremity peripheral neuropathy to obtain a medical opinion addressing whether the Veteran's neuropathies are directly related to herbicide exposure during his service in the Republic of Vietnam.

The appeals for separate ratings for neuritis and neuralgia related to the service-connected bilateral lower extremity peripheral neuropathies were dismissed.